Role of adding ovarian function suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or resume menstruation after chemotherapy: The ASTRRA study - Noh, W C; Lee, J W; Nam, S J (2018)
(Suppl.): Abstr. 502